RUSSIA: LIFE-CYCLE INSIGHTS 

Russian Flag.jpg
Map_Russia.png

IPD’s Russian subscription brings transparency to this highly complex and unique market, offering:

  • Easy-to-use Russian brand,

       biosimilar, and generic drug

       launch tracking schedules

  • Russian litigation tracking and

       in-the-courtroom coverage with 

       real-time updates

  • Personalized consults with local Russian intellectual property analysts​

  • Weekly updates including trending Russian drug topics, recent publications, and​

       loss-of-exclusivity information 

  • Comprehensive Russian clinical development tracking in every major disease class
     

  • Complete drug information with locally reviewed Russian indications

  • Russian API (DMF) information